Applied DNA Schedules Fiscal 2019 First Quarter Financial Results Conference Call for Thursday, February 7, 2019 at 4:30 PM ET
January 31 2019 - 5:00AM
Business Wire
Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it
plans to release financial results for its fiscal 2019 first
quarter ended December 31, 2018 after market close on Thursday,
February 7, 2019. In conjunction with the release, the Company has
scheduled a conference call at 4:30 p.m. Eastern Time that will
also be broadcast live over the Internet.
What:
Applied DNA’s Fiscal 2019 First Quarter
Financial Results Conference Call
When:
Thursday, February 7, 2019, at 4:30 p.m. Eastern Time
Where:
Via phone by dialing +1 844-887-9402 or +1
412-317-6798 and ask for the Applied DNA call; via webcast.
A telephonic replay of the conference call will be available for
one day and may be accessed by calling +1 877-344-7529 or +1
412-317-0088 with the passcode 10127851. The webcast will be
archived in under the IR Calendar portion of the Investors section
of the company’s website.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics, personalized medicine and therapeutics.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance and various other factors
detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
18, 2018 and other reports we file with the SEC, which are
available at www.sec.gov. Applied DNA undertakes no obligation
to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events, unless otherwise
required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190131005049/en/
Investor contact: Sanjay M. Hurry, LHA Investor
Relations, 212-838-3777, shurry@lhai.comWeb:
www.adnas.comTwitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024